Colorcon and ASHA Cellulose Announce New Partnership to Support the Development & Manufacture of Barrier Membrane Formulations for the Pharmaceutical and Nutraceutical Industries
ASHACEL® - a family of multifunctional, water-insoluble, organo-soluble thermoplastic cellulose ethers that serve as binders, flexible film formers, taste-masking and time-release agents, rheology modifiers and more.
ASHAKOTE® - a 30% aqueous dispersion of Ethyl cellulose, suitable for sustained release, taste-masking and moisture control, and used in regions where organic solvents are not acceptable.
"Colorcon is excited to announce our new partnership with ASHA Cellulose to further the support we provide to our customers in barrier membrane and multi-particulate development," said Kurt Fegely, Vice President of Excipient Technologies at Colorcon. "ASHA has been a leader in the cellulosic polymer industry for more than 25 years. Our partnership combines an impressive product portfolio, recognized leadership in controlled release multi-particulate applications and regulatory excellence, helping our customers achieve success in drug delivery."
Raju Shah, President for ASHA Cellulose, commented: "Asha Cellulose has been involved in manufacturing ASHACEL Ethyl Cellulose and ASHAKOTE Aqueous Ethyl Cellulose dispersion using in-house capabilities and a world-class infrastructure. With this partnership, we are confident that the unique combination of our polymer expertise and Colorcon's technical prowess and customer reach will help us serve our customers better."
Simon Tasker, Chief Executive Officer at Colorcon, concluded, "This partnership is a great example of our commitment to the pharmaceutical and nutraceutical industries. We are excited to bring together our two organizations to provide an enhanced product portfolio, high quality manufacturing and dedication to service excellence, supply reliability and technical expertise to our global customers."
This partnership will officially start on May 15th.
About Colorcon
Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, core excipients and functional packaging for the pharmaceutical industry. www.colorcon.com.
About ASHA Cellulose Private Limited
Asha Cellulose (I) Pvt Ltd is a renowned Indian company engaged in manufacturing Ethyl cellulose and other cellulose derivatives, pigment dispersions through its group companies. Asha's Ethyl cellulose polymer and aqueous dispersion, available under the brand names ASHACEL and ASHAKOTE, comply with the requirements of all major pharmacopoeias and the products are well received worldwide in the pharmaceutical and nutraceutical industries. The India-based manufacturing facility is EXCiPACT and ISO 9001, ISO 14001, ISO 14001 and OSHAS 18001 certified. The company has a state-of-the-art infrastructure and manufacturing control facility, ensuring product quality and regulatory excellence.www.ashacel.com
View original content:https://www.prnewswire.com/apac/news-releases/colorcon-and-asha-cellulose-announce-new-partnership-to-support-the-development--manufacture-of-barrier-membrane-formulations-for-the-pharmaceutical-and-nutraceutical-industries-302449368.html
SOURCE Colorcon Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Global Mass Spectrometry Market to Reach USD 9.62 Billion by 2030 Amid Rising Pharmaceutical R&D, Environmental Testing, and AI-Powered Advancements: MarkNtel Advisors
NEW DELHI, Aug. 20, 2025 /PRNewswire/ -- The Global Mass Spectrometry Market size valued at approximately USD 6.9 billion in 2024, is projected to reach USD 10.38 billion by 2030, growing at a CAGR of around 7.04% during the forecast period from 2025 to 2030, according to MarkNtel Advisors. This market growth is driven by heightened concerns for public and environmental health, leading to increased food testing and sample testing. The rapid expansion of the pharmaceutical industry and the integration of AI in mass spectrometers are also pivotal. Various governments are significantly investing in mass spectrometry infrastructure, while hospitals and labs upgrade their medical devices with advanced systems. However, challenges like high operational costs and a shortage of trained professionals persist, especially in remote areas. Overall, these factors create ample growth opportunities for stakeholders in the evolving landscape of analytical techniques, biotechnology innovation, and healthcare quality control. Mass Spectrometry Market Report Scope: Study Period: 2025-2030 Growth Rate (CAGR): 7.04% During 2025-30 Market Size (2024): USD 6.9 Billion Market Value (2030): USD 10.38 Billion Leading Region: North America Interested User Can Get a FREE sample of the report here: Top Mass Spectrometry Manufacturers/Companies Worldwide The Mass Spectrometry Global Market is seeing dynamic activity from top mass spectrometry manufacturers/companies aiming to expand their market share. Key players like Thermo Fisher Scientific Inc., Agilent Technologies Inc., and Waters Corporation are leading the way, alongside Danaher Corporation, Bruker Corporation, and Shimadzu Corporation. Companies such as PerkinElmer Inc., JEOL Ltd., LECO Corporation, and Advion Inc. are actively pursuing mergers, collaborations, and acquisitions to enhance their competitive advantage. Their focus on innovation, research and development, and diverse product portfolios positions them for sustained growth in an evolving industry. With a commitment to improving operational efficiency and addressing market demands, these firms are shaping the future of analytical instruments and driving revenue growth in the mass spectrometry sector. Rising Demand Across Key Sectors Mass spectrometry has become a cornerstone technology for high-precision analytical testing, enabling industries to identify, quantify, and characterize chemical compounds with unmatched accuracy. The surge in adoption is driven by multiple high-growth sectors: Pharmaceuticals & Biotechnology: Increased spending on drug discovery, diagnostics, and biomarker identification is fueling demand. LC-MS and hybrid spectrometers are now essential for nitrosamine impurity testing, compliance with FDA and EMA regulations, and advanced proteomics research. Environmental Testing: With growing concerns around PFAS, microplastics, and nitrosamines, mass spectrometry is emerging as the go-to tool for regulatory bodies such as the U.S. EPA, which has approved LC-MS/MS protocols (Methods 533 & 537.1) for drinking water testing. Food & Beverage Safety: Rising global emphasis on quality assurance (QA) protocols, contaminant detection, and chemical residue analysis is creating new demand for advanced MS solutions. Energy & Climate Research: Mass spectrometers are being deployed for climate modeling, energy exploration, and environmental monitoring, aligning with sustainable development goals. Market Dynamics: Key Drivers Emerging Contaminants Testing: The rapid evolution of contaminants like PFAS, nitrosamines, and microplastics has made mass spectrometry indispensable for compliance and research. Growing Pharma R&D Budgets: With double-digit YOY increases in pharmaceutical R&D spending, mass spectrometry is becoming central to both drug discovery and quality control (QC) processes. Government Regulations: Stringent drug safety protocols, environmental monitoring standards, and food safety laws are pushing adoption globally. Access Complete Data Tables, Forecasts, Segment, and Competitor Profiles Here: Growth Restraints High Cost of Systems: Instruments range from USD 75,000 to USD 500,000 depending on type and configuration, with GC-MS averaging USD 50,000–115,000 and single-mass systems priced at USD 350,000–400,000. Operational & Training Costs: In addition to capital investment, users face maintenance, calibration, reagent, and skilled labor costs. Smaller labs face difficulties due to infrastructure limitations. Skilled Workforce Shortage: Efficient MS usage requires specialized training in sample preparation, method development, and troubleshooting. With only four researchers per 10,000 workers in India and a projected 65,000 bio-economy professionals needed in Canada by 2029, the talent gap could slow adoption. Opportunities Technological Advancements: Breakthroughs in AI integration, machine learning, mass spectrometry imaging (MSI), high-resolution MS (HRMS), and miniaturized portable MS devices are broadening applications across healthcare, forensic science, and diagnostics. OMICS Revolution: Growth in proteomics, genomics, and metabolomics is creating opportunities in personalized medicine, diabetes research, and congenital disorder screening. Portable Solutions: Field-deployable MS systems now allow real-time on-site diagnostics in environmental testing, agriculture, and border security. Future Trends: The global mass spectrometry market is witnessing a significant trend with the integration of artificial intelligence in mass spectrometers. This innovation enhances the efficiency of these medical devices, allowing for faster and more accurate results compared to traditional methods that require manual analysis. Companies like Agilent, Thermo Fisher, Bruker, and Waters are leading the charge in manufacturing AI-enabled mass spectrometers. For example, Thermo Fisher Scientific launched the Orbital Astral Zoom MS in 2025, which utilizes AI software via the Ardia platform for improved multiplexing and scanning speeds. Agilent Technologies also introduced the InfinityLab Pro iQ series in 2025, featuring AI-powered compact Liquid Chromatography-Mass Spectrometry (LC-MS). This system autonomously detects faults and suggests corrections, showcasing how AI advancements are effectively transforming the mass spectrometry landscape. Global Mass Spectrometry Market Segmentation Analysis: By Product Type: Based on mass spectrometry product type segment market is led by instruments, particularly hybrid mass spectrometers. These devices combine different mass analyzers, enhancing sensitivity and accuracy. Their ability to generate complex data quickly drives widespread adoption and necessitates software for data management. By Application: The OMICS research segment is projected to grow notably in mass spectrometry. Its applications in diagnostics and biomarker identification, particularly in biopharma and genomics, are driving advancement, especially in diabetes and newborn screening. By End User: The pharmaceutical sector is expected to see the fastest growth in mass spectrometry. Increased regulations in drug manufacturing and advancements in QC processes are pushing pharmaceutical companies to adopt mass spectrometers, solidifying their dominant position in the market. Regional Insights: North America Leading Growth North America South America Europe The Middle East & Africa Asia-Pacific North America leads the mass spectrometry market, holding a 38% share, thanks to its robust pharmaceutical and biotech sectors. Key companies like Pfizer, Johnson & Johnson, and Merck in the U.S., along with Canada's Apotex, drive innovation in drug discovery and testing. Significant government and private funding for R&D, such as grants from the National Institutes of Health and the Canada Foundation for Innovation, further bolster the region's market position. These investments highlight North America's prominent role in advancing mass spectrometry technology. Request Your Custom Global Mass Spectrometry Market Report – Regional or Country Specific – Get tailored insights for your exact target market. Related Questions You May Find Helpful: Q1: How big is the global mass spectrometry market? The market was USD 6.33 billion in 2024 and is projected to reach USD 9.62 billion by 2030 at a 7.2% CAGR, driven by pharma R&D, food safety testing, and environmental monitoring. Q2: How expensive is a mass spectrometer? Costs range from USD 75,000 to USD 500,000. GC-MS averages USD 50,000–115,000, while advanced hybrid and high-resolution systems exceed USD 400,000. Q3: What are the latest advancements in mass spectrometry market? In 2025, Agilent Technologies Inc. introduced the InfinityLab Pro iQ Series, which includes the Pro iQ and Pro iQ Plus LC–MS detectors designed for quicker, smarter, and more automated laboratory processes. Alongside, they upgraded the 8850 GC system for compatibility with mass spectrometry. These innovations are smaller, faster, and more eco-friendly, earning certification from My Green Lab for sustainability. Q4: What are the future trends of mass spectrometry? Integration of artificial intelligence with MS devices is one of the key trends shaping the growth of the Mass Spectrometry Market. Q5: What are the downsides of mass spectrometry? Challenges include high upfront costs, ongoing consumable expenses, complex operation, infrastructure needs, and a global shortage of skilled analysts. Q6: What is the difference between MS, MS/MS, and LC-MS? MS identifies compounds by mass-to-charge ratio. MS/MS (tandem MS) provides deeper structural data using two analyzers. LC-MS couples liquid chromatography with MS for separating complex mixtures before analysis. Q7: How is mass spectrometry used in the pharmaceutical industry? Pharma companies rely on MS for drug discovery, nitrosamine impurity profiling, biologics QC, biomarker validation, and regulatory compliance testing. Q8: Do hospitals and clinical labs use mass spectrometry? Yes. Hospitals use MS for toxicology, newborn screening, infectious disease biomarker testing, therapeutic drug monitoring, and personalized medicine diagnostics. Q9: What is the difference between NMR and MS? NMR uses magnetic resonance to analyze molecular structure. MS determines mass-to-charge ratios for chemical identification and are complementary in drug development and biomolecular research. Q10: Who are the leaders and manufacturers in the mass spectrometry market? Key players include Agilent, Thermo Fisher, Danaher (SCIEX), Waters, Bruker, Shimadzu, PerkinElmer, JEOL, and Hitachi High-Tech. Q11: Why are spectrometers so expensive? They require precision engineering, high-tech detectors, proprietary software, costly consumables, and rigorous calibration standards, which increase price. Q12: What industries will drive future MS adoption? Growth will be strongest in pharma & biotech, food & beverage safety, environmental testing, clinical diagnostics, energy/petrochemicals, and forensic sciences. MarkNtel Blogs: Key Players Boosting Japan Anime Merchandising Industry Growth - Top AV Cable Companies Driving Residential Connectivity in South Korea - Top Companies in Japan Wax Industry - India Sports Nutrition Top Brands to Watch in 2025 - Top Companies Operating in Online Gaming Market - Key Brands in India Bath Soap Market - Top 10 Electric Vehicle Companies in India 2025: From Startups to Auto Giants- Top 7 ATM Companies Shaping the Global Market Landscape - Top Pan Masala Brands in India - About Us MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others. We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others. Logo: Contact Us:MarkNtel AdvisorsOffice No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, IndiaContact No: +91 8719999009Email: sales@ Visit our Website: Content Source: View original content: SOURCE MarkNtel Advisors
Bloomberg
5 hours ago
- Bloomberg
Quadria Is Said to Weigh Stake Sale in $2 Billion Firm Encube
Asian healthcare-focused private equity firm Quadria Capital is considering selling its minority stake in Indian topical pharmaceutical company Encube Ethicals Pvt, people familiar with the matter said. Quadria Capital is discussing with prospective advisers a potential exit from the Mumbai-based company and seeking a valuation of $2 billion for the entire business, the people said, asking not to be identified as the discussions are private. The considerations are preliminary and no final decisions have been made, the people said.
Yahoo
5 hours ago
- Yahoo
India waives customs duty on cotton imports to support textile sector
This waiver includes the elimination of a 5% Basic Customs Duty (BCD), a 5% Agriculture Infrastructure and Development Cess (AIDC), and a 10% Social Welfare Surcharge, which together constituted an 11% import duty on cotton. The Central Board of Indirect Taxes and Customs (CBIC) announced this decision with the expectation that it will reduce input costs throughout the textile value chain, including yarn, fabric, garments, and made-ups. The move is anticipated to provide relief to apparel and textile manufacturers and consumers. The exemption may be an advantage for US cotton producers and support India's clothing sector, which is bracing for tariffs close to 60% on its US exports starting later this month, according to Reuters. The textile industry has been advocating for the removal of import duties on cotton due to escalating domestic prices and supply constraints. The Indian government's decision to waive these duties aims to increase raw cotton availability in the domestic market, stabilise prices to curb inflation on textile products, enhance the export competitiveness of Indian textiles by reducing production costs, and protect small and medium-sized enterprises in the textile sector from price volatility, according to the Ministry of Textiles. This initiative is projected to positively impact domestic cotton prices and fortify the health of India's textile and apparel sector — a vital source of employment and exports. Textile associations have expressed their approval of this measure by the government, which exempts all varieties of cotton from an 11% import duty starting 19 August. Earlier this month (August), US President Donald Trump imposed additional tariffs on Indian products as a response to India's purchase of Russian oil, effectively doubling the total duty to 50% on Indian imports into the US from later this month. Prior to the tariff increase by Trump in April, Indian exports were subject to duties ranging from 0-5%, with some textile products facing tariffs between 9% and 13%, reported the news agency. "India waives customs duty on cotton imports to support textile sector" was originally created and published by Just Style, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
